Selecting Appropriate Therapy in the Evolving Treatment Landscape of Plaque Psoriasis
Expert dermatology physician assistants share how to select the appropriate therapy for your patient with plaque psoriasis in an expanding treatment landscape.
Read More
Patient Experience With Oral Systemic Treatments
TJ Chao and Kristine Kucera, PA’s share their insights into the patient experience with oral systemic agents for plaque psoriasis.
Impact of the Expanding Treatment Landscape on the Treatment Algorithm of Plaque Psoriasis
TJ Chao and Kristine Kucera, PA’s discuss the changing treatment algorithms of plaque psoriasis with the arrival of novel agents such as the TYK2 inhibitors.
Safety Data on Deucravacitinib
Advances practice providers in dermatology discuss the safety data on the novel TYK2 inhibitor deucravacitnib.
Recent Long Term Clinical Trial Data on Deucravacitinib
Dermatology physician assistants review the short- and long-term clinical trial data on deucravacitinib.
Lab Requirements and Monitoring of Deucravacitinib Treatment
Dermatology physician assistants review the laboratory and monitoring requirements for TYK2 inhibitors deucravacitinib.
The Oral Systemic Space of Plaque Psoriasis
TJ Chao and Kristine Kucera, PA’s go into dept of the recent developments in the systemic oral space of plaque psoriasis.
Plaque Psoriasis as a Systemic Disease
Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease.
The Evolving Role of Advanced Practice Providers Treating Plaque Psoriasis
Dermatology physician assistants are talking about the evolving role of their profession in taking care of patients with plaque psoriasis.
Overview of the Recent Development in the Treatment Landscape: Plaque Psoriasis
Advances practice providers TJ Chao, MPAS, PA-C and Kristine Kucera, PA-C, MPAS, DHS discuss the recent development in the treatment landscape of plaque psoriasis.